Edesa Share Price

Edesa Share Price

NASDAQ: EDSA | Micro Cap | Healthcare
$2.07
+$0.11 (5.61%) Last updated on 19 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Corporate Actions
  • About
  • Price history
  • FAQs

Edesa Stock Performance

Open
$2.13
Prev. Close
$1.96
Circuit Range
N/A
Day Range
$2.04 - $2.13
Year Range
$0.81 - $19.61
Volume
4,436
Average Traded
$2.11

Edesa Share Price Today

As of 19 November 2026, Edesa Biotech, Inc.'s share price is $2.07. The stock opened at $2.13, compared to its previous close of $1.96. During today's trading session, Edesa Biotech, Inc.'s share price traded between $2.04 and $2.13, with an average price of $2.09. Over the past 52 weeks, the stock has recorded a high of $19.61 and a low of $0.81. In terms of performance, Edesa Biotech, Inc.'s share price has declined by 71.59% over the last six months and is up 19.65% on a year-on-year basis.

Edesa Share Price Chart

Line chart of the Edesa price trend over the selected period. The price rose overall, ranging from 2.02 to 2.19, ending at 2.07.
$2.04$2.13
L
Show Current Price
H

Edesa Stock Fundamentals & Key Indicators

Market Cap
$11.75M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.46
Revenue (TTM)
$0.00
Return On Equity (TTM)
-160.05%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-142.60%

Edesa Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$2.23-$2.25-$4.22-$5.41
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-0.90%-87.56%-28.20%

Edesa Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.00
Net Profit-$17.55-$8.37-$6.17-$7.19
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A52.31%26.28%-16.53%

Edesa Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets2.022.142.452.48
Current Assets11.511.686.449.09
Total Assets13.533.818.8911.58
Non Current Liabilities0.00.00.020.04
Current Liabilities1.081.831.822.14
Total Liabilities1.081.831.842.18
Shareholders' Equity12.451.987.059.39

Edesa Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-7.32-4.89-6.64-12.28
Investing0.00.00.0-0.01
Financing17.030.594.8311.63

Corporate Actions

Split
Ex-date: 11 Oct 2023

About Edesa

Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.

Edesa Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$2.61
$2.07
-18.82%
Oct 2026
$3.96
$2.55
-39.72%
Sep 2026
$5.01
$4.23
-11.87%
Aug 2026
$5.18
$4.80
-5.97%
Jul 2026
$7.77
$5.11
-37.32%
Jun 2026
$6.55
$8.14
+11.81%
May 2026
$19.61
$7.29
-60.04%
Apr 2026
$5.65
$18.23
+242.67%
Mar 2026
$2.01
$5.32
+143.48%
Feb 2026
$1.22
$2.19
+90.00%
Jan 2026
$1.49
$1.15
-21.50%
Dec 2025
$1.73
$1.47
-15.32%

Edesa Share Price FAQs